Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab plus axitinib vs sunitinib in advanced renal cell carcinoma (Japan)
jRCT2080223120Phase 3Completed
- Start
- Feb 2016
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 3, randomised trial in renal cell carcinoma (RCC) comparing Avelumab + axitinib with Sunitinib (2 arms). Started Feb 2016; status: completed.
02
Drugs
avelumabaxitinibsunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on jRCT2080223120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223120.